02RESEARCH
We connect medicine, pharmacy, and data science to pursue more precise healthcare for every individual.
The six research areas set out in the curriculum regulations. All research information on this page falls within this scope.
Research in the department, grouped into six themes that run from molecular discovery through data interpretation to clinical translation. The official classification is the six research areas above.
High-sensitivity detection, analysis, and biosensor technologies identify disease signals and biomarkers with precision.
No professor has registered keywords for this theme yet.
Filter the faculty directory by this theme
Fundamental discoveries advance into patient-centered clinical research and validation in real healthcare settings.
No professor has registered keywords for this theme yet.
Filter the faculty directory by this theme
Clinical, imaging, and biosignal data converge in predictive models and clinical decision-support research.
No professor has registered keywords for this theme yet.
Filter the faculty directory by this theme
Computational biology integrates genomic, transcriptomic, proteomic, and metabolomic layers to interpret individual variation.
No professor has registered keywords for this theme yet.
Filter the faculty directory by this theme
Nanobiological delivery systems combine with sensors and integrated devices to improve diagnostic and therapeutic precision.
No professor has registered keywords for this theme yet.
Filter the faculty directory by this theme
Pharmacogenomics and precision pharmacology reveal treatment responses and guide the search for new therapeutic strategies and drug candidates.
No professor has registered keywords for this theme yet.
Filter the faculty directory by this themeThe questions each major asks and the methods it uses.
We interpret individual differences in patients and diseases through molecular and clinical data, then translate those insights into diagnosis and treatment.
We develop predictive models and clinical decision-support systems using medical big data and bioinformatics.
We investigate disease targets and drug responses while advancing candidate compounds, delivery technologies, and translation to real-world impact.
